Please enable JavaScript or talk to your local administrator to get JavaScript enabled.


Ascertaining the role of mutations in COMPASS-like complex members in the development of upper tract urothelial carcinoma

Funder: Bladder Cancer Advocacy Network

Funding period
USD 50 K
Funding amount
Upper tract urothelial carcinoma (UTUC) is a relatively rare malignancy and only accounts for 5-10% of all urothelial carcinomas. Nonetheless, management of high risk UTUC requiring radical nephrouretrectomy remains particularly challenging since only select patients have adequate renal function to tolerate cisplatin-based chemotherapy and few other proven therapeutic options exist. Cisplatin-ineligible patients with recurrent or metastatic disease who do not respond to immunotherapy have a dismal prognosis. Recent genomic studies have identified mutations in Complex of Proteins Associated with Set1(COMPASS)-like complex members in 66% of UTUC patients, but how these mutations drive UTUC carcinogenesis is virtually unknown. Our research is focused on how inactivating mutations in the COMPASS-like complex members, KMT2C, KMT2D, and KDM6A, lead to gene expression changes that support UTUC initiation and progression. In addition, we are exploring whether these mutations create a dependency on specific signaling pathways that can be exploited using novel therapies.
Similar projects All >
Sorted by: Start Date
Project list item
Upper tract urothelial carcinoma is non-basal and T-cell depleted

Bladder Cancer Advocacy Network to Panagiotis Vlachostergios

USD 1,700
2018 - 2018
Project list item
Next generation sequencing to enhance initial staging and dynamically monitor disease response in upper tract urothelial carcinoma

Bladder Cancer Advocacy Network to Philip Abbosh, Wafik El-Deiry, Elizabeth Plimack

USD 50,000
2018 - 2019
Project list item
Investigation of anti-tumor effect of Axl kinase inhibitor in urothelial carcinoma.

Japan Society for the Promotion of Science to Seiya Hattori

USD 33,260
2014 - 2016
Project list item
Staging of upper tract urothelial cancer with optical coherence tomography

National Cancer Institute to ANDREW MARTIN ROLLINS, HUI ZHU

USD 548,995
2012 - 2015
Project list item
The efficacy of renin-angiotensin system blockade for upper tract urothelial carcinoma

Japan Society for the Promotion of Science to Nobuyuki TANAKA

USD 45,791
2012 - 2014



    1112 Oncology and Carcinogenesis

  • RCDC


  • RCDC

    Urologic Diseases



  • Health Research Areas


  • Broad Research Areas

    Clinical Medicine and Science